Affiner les résultats

Quantitative monitoring of tamoxifen in human plasma extended to 40 metabolites using liquid-chromatography high-resolution mass spectrometry: new investigation capabilities for clinical pharmacology

Dahmane, Elyes ; Boccard, Julien ; Csajka, Chantal ; Rudaz, Serge ; Décosterd, Laurent ; Genin, Eric ; Duretz, Bénédicte ; Bromirski, Maciej ; Zaman, Khalil ; Testa, Bernard ; Rochat, Bertrand

In: Analytical and Bioanalytical Chemistry, 2014, vol. 406, no. 11, p. 2627-2640

Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre

Jermini, Mégane ; Dubois, Julie ; Rodondi, Pierre-Yves ; Zaman, Khalil ; Buclin, Thierry ; Csajka, Chantal ; Orcurto, Angela ; Rothuizen, Laura E .

In: Scientific Reports, 2019, vol. 9, no. 1, p. 5078

Complementary medicine (CM) is used by one third to one half of cancer patients throughout the world. The objective of this study was to describe the prevalence of CM use and the potential for interactions with cancer treatments in an academic oncology centre. A cross-sectional study was conducted among patients undergoing current cancer treatment. Among 132 included patients, 56% had used CM...

Primary clear cell sarcoma of the ileum: an uncommon and misleading site

Taminelli, Lorenzo ; Zaman, Khalil ; Gengler, Carole ; Peloponissios, Nicolas ; Bouzourene, Hanifa ; Coindre, Jean-Michel ; Hostein, Isabelle ; Guillou, Louis

In: Virchows Archiv, 2005, vol. 447, no. 4, p. 772-777

Improving Breast Cancer Education: The Case of an Evolving Multidisciplinary Module for Undergraduate Medical Students (Lausanne Medical School, 1993-2008)

Fiche, Maryse ; Lepori, Domenico ; Guntern, Daniel ; Jucker-Kupper, Patrick ; Jeanneret, Wendy ; Zaman, Khalil ; Vadot, Sara ; Delaloye, Jean-François

In: Journal of Cancer Education, 2010, vol. 25, no. 1, p. 101-105

Proangiogenic factor PlGF programs CD11b+ myelomonocytes in breast cancer during differentiation of their hematopoietic progenitors

Laurent, Julien ; Faes-van't Hull, Eveline ; Touvrey, Cedric ; Kuonen, François ; Lan, Qiang ; Lorusso, Girieca ; Doucey, Marie-Agnès ; Ciarloni, Laura ; Imaizumi, Natsuko ; Alghisi, Gian Carlo ; Fagiani, Ernesta ; Zaman, Khalil ; Stupp, Roger ; Shibuya, Masabumi ; Delaloye, Jean-François ; Christofori, Gerhard ; Rüegg, Curzio

In: Cancer Research, 2011, vol. 71, no. 11, p. 3781-3791

Tumor-mobilized bone marrow-derived CD11b+ myeloid cells promote tumor angiogenesis, but how and when these cells acquire proangiogenic properties is not fully elucidated. Here we show that CD11b+ myelomonocytic cells develop proangiogenic properties during their differentiation from CD34+ hematopoietic progenitors and that Placenta Growth Factor (PlGF) is critical in promoting this ...